EXAS stock forecast
Our latest prediction for EXACT Sciences Corp.'s stock price was made on the Feb. 28, 2019 when the stock price was at 91.00$.
In the short term (2weeks), EXAS's stock price should outperform the market by 0.82%. During that period the price should oscillate between -6.91% and +7.83%.
In the medium term (3months), EXAS's stock price should outperform the market by 4.96%. During that period the price should oscillate between -16.24% and +23.10%.Get email alerts
About EXACT Sciences Corp.
EXACT Sciences Corp. is a molecular diagnostics company, which focuses on the early detection and prevention of colorectal cancer. It developed Cologuard, a screening test for the early detection of colorectal cancer and pre-cancer. The company was founded on February 10, 1995 and is headquartered in Madison, WI.
At the moment the company generates 724M USD in revenues.
On its last earning announcement, the company reported a loss of -1.70$ per share.
The book value per share is 6.06$
Three months stock forecastFeb. 28, 2019
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|